Saxenda has a list price of $1,349.02 for a 30-day supply, but you can pay significantly less without insurance by combining discount programs, pharmacy shopping, and manufacturer assistance. The key is knowing where to look, because the price difference between pharmacies alone can be nearly $900 for the same box of pens.
Use a Pharmacy Discount Coupon
The single biggest savings tool for uninsured Saxenda buyers is a free pharmacy discount coupon from platforms like GoodRx or SingleCare. These aren’t insurance. They’re pre-negotiated prices that vary dramatically by pharmacy. As of mid-2026, GoodRx coupon prices for one carton of Saxenda (five pens) range from about $372 at Walgreens to over $1,200 at Walmart and Costco. That’s a 75% discount off the average retail price at the cheapest option.
Here’s what the price landscape looks like for the same five-pen carton:
- Walgreens: ~$372
- Hy-Vee: ~$385
- CVS Pharmacy: ~$698
- Walmart: ~$1,237
- Costco: ~$1,234
The takeaway: always check coupon pricing at multiple pharmacies before filling your prescription. Prices shift over time, and the cheapest option today may not be the cheapest next month. You don’t need a membership or signup to use most of these coupons. Just pull up the price on the app or website, show it to your pharmacist, and they apply the discount at checkout.
Novo Nordisk’s Savings Card
Novo Nordisk, the company that makes Saxenda, offers a savings card that knocks $200 off your monthly cost. The card covers up to 12 prescription fills per patient. If you’re already using a discount coupon that brings the price down to the $370 range, stacking this savings card could theoretically lower your out-of-pocket cost even further, though the specific terms of combining discounts can vary. Check the current terms on the Saxenda website, as program details change periodically.
The Patient Assistance Program
If you’re uninsured and your household income is low enough, you may qualify for Novo Nordisk’s Patient Assistance Program, which provides medications at no cost. The eligibility requirements for 2026 are straightforward: you must be a U.S. citizen or legal resident, have no insurance (or have Medicare without qualifying for other federal programs), and your total household income must fall at or below 400% of the federal poverty level. For a single person in 2025, that’s roughly $60,000 per year.
You’re not eligible if you have private or commercial insurance, or if you qualify for Medicaid, Medicare’s Low Income Subsidy (Extra Help), or VA benefits. If you’ve been denied Medicaid or Medicare LIS, you’ll need to submit your denial letter with your application. The application process goes through your prescribing doctor, so you’ll need an active prescription and a provider willing to help with the paperwork.
Getting a Prescription Without a Doctor’s Office Visit
If you don’t have a primary care doctor or want to avoid office visit fees, telehealth services can prescribe Saxenda remotely. GoodRx offers a weight loss telemedicine subscription where a licensed provider evaluates whether you’re a candidate for FDA-approved GLP-1 medications, including Saxenda. The standard price is $119 per month for ongoing virtual consultations. Other telehealth platforms offer similar services at varying price points. Keep in mind this subscription fee covers only the consultation and prescription. You still pay separately for the medication itself.
A Generic Version Now Exists
In December 2024, the FDA approved the first generic version of liraglutide injection, made by Hikma Pharmaceuticals. The approval references Victoza (the diabetes-branded version of the same drug), not Saxenda specifically, but both contain liraglutide. Whether your doctor can prescribe generic liraglutide off-label for weight loss, and how pharmacies price it, is worth asking about. Generic versions of brand-name drugs typically cost less, though availability can lag behind approval by months.
How Saxenda Compares to Other GLP-1 Options
If the out-of-pocket cost of Saxenda still feels steep, it’s worth knowing that some competing medications have launched direct-to-consumer pricing programs that may be cheaper. Novo Nordisk now sells Wegovy (a once-weekly injection in the same drug class) through its NovoCare Pharmacy for $349 per month, with a Wegovy pill version available for $149 per month. Eli Lilly sells Zepbound single-dose vials for $299 to $449 per month through LillyDirect.
These prices are specifically for self-pay patients buying directly from the manufacturer’s pharmacy programs. They change the math considerably. Saxenda at its best coupon price ($372) is comparable to Wegovy’s pen price ($349), but Saxenda requires daily injections while Wegovy is once weekly. For many people paying cash, the newer options offer better convenience at a similar or lower price point. Talk to your provider about whether switching makes sense for your situation.
Why Compounded Versions Are Risky
You may see online pharmacies or wellness clinics advertising cheaper compounded versions of GLP-1 drugs. Compounded medications are mixed by specialty pharmacies rather than manufactured by the original drug company, and they are not reviewed by the FDA for safety, effectiveness, or quality before being sold.
The FDA has flagged serious concerns with compounded GLP-1 products. As of July 2025, the agency had received over 1,100 adverse event reports linked to compounded semaglutide and tirzepatide, with some cases requiring hospitalization due to dosing errors. Problems include patients measuring incorrect doses from bulk vials, products arriving warm without proper refrigeration, and outright fraudulent products with fake pharmacy names on the labels. Some compounders have used salt forms of semaglutide (like semaglutide sodium or semaglutide acetate) that are chemically different from the active ingredient in approved drugs, and the FDA says there’s no lawful basis for their use.
Compounded liraglutide specifically hasn’t generated the same volume of reports, but the same quality and safety gaps apply. If cost is driving you toward compounded products, the manufacturer pricing programs described above may offer a safer path to a similar price point.